Redwood City, CA, United States of America

Daniel Baldoni

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Daniel Baldoni in Blood Glucose Modulation

Introduction

Daniel Baldoni is an innovative inventor based in Redwood City, CA. He has made significant contributions to the field of medical technology, particularly in the treatment of blood glucose abnormalities, including type 2 diabetes. His work focuses on developing systems and methods that utilize electrical signals to improve patient outcomes.

Latest Patents

Baldoni holds a patent for "Therapeutic modulation to treat blood glucose abnormalities, including type 2 diabetes, and/or reduce HBA1C levels, and associated systems and methods." This patent describes systems and methods for treating patients with blood glucose abnormalities, such as type 2 diabetes (T2D), through the use of an electrical signal. A representative method involves positioning at least one implantable signal delivery device near a target location at the patient's spinal cord, specifically within a vertebral range from about C8 to about T12. The method includes directing an electrical signal to this target location via the implantable device, with the signal frequency ranging from 1.2 kHz to 100 kHz. Baldoni has 1 patent to his name.

Career Highlights

Daniel Baldoni has established himself as a key figure in the medical technology sector. His innovative approach to treating diabetes through electrical modulation has the potential to transform patient care. He is currently associated with Nevro Corporation, a company known for its advancements in neuromodulation therapies.

Collaborations

Baldoni collaborates with various professionals in the field, including his coworker Satinderpall Singh Pannu. Their combined expertise contributes to the development of cutting-edge solutions for managing blood glucose levels.

Conclusion

Daniel Baldoni's work in therapeutic modulation represents a significant advancement in the treatment of type 2 diabetes. His innovative patent and collaboration with Nevro Corporation highlight his commitment to improving patient health through technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…